ChemCon has received approval, following a successful inspection by the German health authorities in July 2013, to manufacture semi-solid pharmaceuticals (gels and creams for topical therapy) for human use.
 
ChemCon will now offer services that include the early R&D stages of drug development, the transfer of the manufacturing process to production under GMP conditions, and the production of drug product samples for clinical trials for both placebo and active treatment arms.
 
The company recently completed a project for the production of both the placebo and active ingredient for Phase II trials. The company manufactured the API and then created of both placebo and API containing gel samples, which were then randomized by ChemCon and delivered to the clinical trials center.